Over the last few years, one topic has generated increasingly lively discussion among pet owners, veterinary professionals and the wider CBD industry: the relationship between conventional veterinary medicines and CBD. One of the most searched questions in 2026 was “Where can I buy CBD for my Dog“? That tells us something.
To some people, it appears that a confrontation is inevitable. Social media often presents the situation as though there are two opposing sides-traditional veterinary medicine on one side and CBD on the other.
But is that really what is happening?
In reality, the situation is far more nuanced than many headlines suggest. Rather than a “war”, what we’re seeing is the challenge of balancing innovation, consumer demand, scientific evidence and regulation.
Understanding those different perspectives helps explain why CBD continues to generate discussion throughout the veterinary world.
Why Has the Conversation Become So Prominent?
There is little doubt that CBD has become far more familiar to consumers than it was ten years ago.
People have become accustomed to seeing CBD products in health stores, pharmacies, online retailers and supermarkets. Naturally, many pet owners have wondered whether similar products exist for their dogs.
At the same time, owners are investing more in every aspect of pet care than ever before. Premium nutrition, supplements, enrichment products and preventative healthcare have all experienced significant growth.
CBD has become part of that broader conversation.
As consumer awareness has increased, so too has the need for regulators to decide how these products should fit within existing veterinary legislation.
The Veterinary Profession Has a Different Responsibility
One important point that is sometimes overlooked is that veterinary surgeons have a very different role from retailers or manufacturers.
A vet’s primary responsibility is to diagnose disease, protect animal welfare and prescribe appropriate treatment based on clinical judgement and the evidence available.
That responsibility naturally makes the profession cautious whenever new products emerge.
Caution should not automatically be interpreted as opposition.
Veterinary medicine has always evolved carefully as new treatments become available. New medicines typically undergo years of research, safety assessment and regulatory review before becoming widely adopted.
That cautious process exists to protect animals.
Why the VMD Takes the Current Position
In the United Kingdom, the Veterinary Medicines Directorate (VMD) considers products containing CBD that are intended for animals to fall within the definition of veterinary medicines. This means they require a veterinary marketing authorisation before they can legally be sold or supplied for use in animals. At present, there are no CBD products authorised in the UK specifically for veterinary use.
This regulatory position sometimes surprises pet owners because CBD products for humans are widely available.
However, human products and veterinary medicines are regulated under different legal frameworks.
The distinction is important.
Does That Mean Vets Are Against CBD?
Not necessarily.
There is an important difference between being cautious and being opposed.
Veterinary professionals work within professional and legal responsibilities. They must follow the Veterinary Medicines Regulations and make decisions that reflect both the available evidence and the regulatory framework.
Where appropriate, UK regulations allow a veterinary surgeon to prescribe a legally obtained human CBD product under the prescribing cascade, but this is a clinical decision for the vet and not something owners should do independently.
That is very different from saying the profession is “at war” with CBD.
Why Some Owners See Tension
Many pet owners encounter stories online from countries where CBD products for animals are marketed differently.
When they compare that with the UK’s regulatory approach, it can appear as though someone is preventing access.
In reality, much of the difference comes down to regulation rather than conflict.
Different countries have adopted different approaches to CBD, and businesses must operate within the rules that apply in their own jurisdiction.
Scientific Interest Continues to Grow
Another reason the conversation remains active is that scientific interest in cannabinoids continues to develop.
Researchers around the world are studying cannabinoids in both human and veterinary medicine, and new studies continue to be published.
Scientific progress, however, does not automatically change regulatory requirements.
Regulators generally evaluate the totality of available evidence before changing policies or approving new veterinary medicines.
That process often takes years rather than months.
The Role of Pharmaceutical Companies
Some commentators suggest pharmaceutical companies see CBD as a threat.
Others argue that pharmaceutical companies themselves are investing in cannabinoid research.
The reality is likely to be more complicated than either of those simple narratives.
The pharmaceutical industry has a long history of researching naturally derived compounds.
Many modern medicines originate from plants, fungi or naturally occurring substances.
Whether future veterinary medicines eventually include cannabinoid-based products will depend on scientific evidence, regulatory approval and demonstrated standards of safety, quality and efficacy-not simply on public demand.
Consumers Are Driving Change
Perhaps the biggest influence is neither regulators nor manufacturers.
It is consumers.
Today’s pet owners ask far more questions than previous generations.
They read ingredient labels.
They compare manufacturers.
They expect transparency.
They look for independent laboratory testing.
They want companies to explain exactly what is inside a product.
That change in consumer behaviour has encouraged higher standards throughout the wider CBD industry.
Quality Has Become Central
Regardless of someone’s opinion on CBD, most people agree on one point.
Quality matters.
Consumers increasingly expect:
- Clear ingredient lists.
- Transparent manufacturing standards.
- Independent laboratory testing.
- Responsive customer support.
- Honest educational information.
These expectations benefit responsible manufacturers and informed consumers alike.
Independent Laboratory Testing
Independent laboratory testing has become one of the strongest indicators of transparency within the CBD industry.
Certificates of Analysis prepared by independent laboratories provide additional information about cannabinoid content and demonstrate that products have undergone external testing.
Many experienced consumers now regard laboratory testing as an essential part of evaluating any CBD product.
Ingredient Quality
Consumers are also paying much closer attention to ingredients than they did only a few years ago.
Rather than looking solely at the amount of CBD, many now examine the complete formulation.
Carrier oils, flavourings and supporting ingredients all contribute to the finished product.
CBD-UK has specialised in CBD since 2016 and places emphasis on transparency throughout its product range. Its salmon CBD oils use human-grade salmon oil, reflecting the company’s focus on carefully selected ingredients and clear product information.
Understanding the complete formulation provides a more balanced assessment than concentrating on a single ingredient.
Better Conversations Benefit Everyone
One positive outcome of the growing interest in CBD is that discussions have become more informed.
Consumers ask better questions.
Manufacturers provide more information.
Independent laboratory testing is increasingly expected.
Veterinary professionals continue to emphasise evidence-based decision-making and individual patient care.
These developments encourage higher standards across the industry.
Looking Ahead
Will there eventually be more authorised cannabinoid-based veterinary medicines?
It is impossible to say with certainty.
That decision will depend on future scientific evidence, regulatory assessment and formal marketing authorisation processes.
What seems more likely is that discussions surrounding CBD, veterinary medicine and pet wellbeing will continue to evolve as new evidence becomes available.
A Conversation Rather Than a Conflict
It is tempting to describe the relationship between veterinary medicine and CBD as a battle, but that probably oversimplifies a far more complex situation.
Veterinary professionals have legal and ethical responsibilities. Regulators have a duty to oversee veterinary medicines. Manufacturers must comply with the rules that apply to them. Consumers naturally want access to safe, high-quality products and clear information.
Those different priorities do not necessarily place everyone on opposing sides.
Instead, they represent different parts of the same conversation.
As research develops and regulations continue to evolve, the most sensible approach for pet owners remains unchanged: seek advice from your veterinary surgeon, rely on factual information, choose transparent manufacturers that value quality and independent laboratory testing, and make decisions based on evidence rather than speculation.
